Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 1

Research Article

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats

Table 1

Protocol for treatments during the acute exacerbation and risk window phases in COPD rats.

Group⁢AE phaseRW phase
(Day −1, 0, Day 2 to Day 6)(Day 7 to Day 16)
NSTSGMXFSTLNSBYGSTL

Control++
COPD++
AECOPD++
TSG/NS++
MXF+STL/NS+++
TSG/BYG++
MXF+STL/STL+++
TSG+MXF+STL/BYG+STL+++++

Note: +: treated with this medicine; −: not treated with this medicine. AE: acute exacerbation; AECOPD: acute exacerbation of chronic obstructive pulmonary disease; BYG: Bufei Yishen Granule; COPD: chronic obstructive pulmonary disease; MXF: moxifloxacin; NS: normal saline; RW: risk window; TSG: Tongsai Granule; STL: salbutamol.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.